Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm
Mandate

Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm

May 09, 2011

Vinge advises in connection with FinnvedenBulten's application to be listed on NASDAQ OMX Stockholm and Nordic Capital's offering of shares in connection therewith. Expected start of trading is on May 20, 2011. Handelsbanken Capital Markets and Carnegie Investment Bank are Joint Lead Managers and Joint Book Runners in the offering.

Vinge's project team is composed primarily of Göran Nyström, Pontus Enquist, Dain Nevonen and Christoffer Benninge as well as Lennart Larsson and Lina Hansson regarding tax matters.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025